| Dystonia Treatment With Injections Supplemented By Transcranial Magnetic Stimulation (NCT04916444) | University of Florida | 2022-02-07 |
| Efficacy and Safety of 10-Week or Shorter vs 12-Week or Longer Injection Intervals of Botulinum Toxin (NCT05103202) | University of Texas Southwestern Medical Center | 2021-11-04 |
| Extension Study of ABP-19000 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 in Cervical Dystonia (NCT04871451) | AEON Biopharma, Inc. | 2021-07-27 |
| A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical Dystonia (NCT04849988) | AEON Biopharma, Inc. | 2021-03-29 |
| Long-term Outcome of DBS Versus Botulinum Toxin Treatment in Cervical Dystonia (NCT04432285) | Oslo University Hospital | 2020-08-06 |
| Conversion to Dysport in CD (NCT04270214) | Western University, Canada | 2020-06-01 |
| Clinical Trial to Compare the Safety and Efficacy of Botulax® Versus Botox® in Patients With Cervical Dystonia (NCT04171258) | Hugel | 2020-05-26 |
| Tele-yoga and Dystonia (NCT04348669) | Rutgers, The State University of New Jersey | 2020-04-28 |
| Abobotulinum Toxin and Neubotulinum Toxin Injection in Cerivical Dystonia (NCT03805152) | Department of Medical Services Ministry of Public Health of Thailand | 2019-10-25 |
| Relief of Pain in Patients With Cervical Dystonia Through the Use of Transcutaneous Electric Nerve Stimulation (TENS) (NCT04949594) | Central Hospital, Nancy, France | 2019-10-21 |
| A Trial of Non-invasive Stimulation in Cervical Dystonia (NCT04057911) | Western University, Canada | 2019-09-01 |
| Physiotherapy and Botox for Cervical Dystonia: Impact of Sensory Tricks and Brain Imaging Insights (NCT06881147) | IRCCS San Raffaele | 2019-04-13 |
| Telemedicine Follow-up for Patients With Cervical Dystonia Treated With Neurotoxin Injections (NCT03969537) | Vanderbilt University Medical Center | 2019-04-01 |
| Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-OLS) (NCT03617367) | Revance Therapeutics, Inc. | 2018-09-05 |
| Single Treatment of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-1) (NCT03608397) | Revance Therapeutics, Inc. | 2018-06-20 |
| Non-Motor Features of Cervical Dystonia (CD) (NCT03471923) | Vanderbilt University Medical Center | 2018-03-26 |
| tDCS in Cervical Dystonia (NCT02180139) | University of Minnesota | 2017-09-01 |
| Safety and Tolerability of Perampanel in Cervical Dystonia (NCT02131467) | University Health Network, Toronto | 2017-09-01 |
| Neurophysiologic Study of Patient With Essential Tremor and Dystonic Tremor (NCT03041714) | National Institute of Neurological Disorders and Stroke (NINDS) | 2017-04-07 |
| Cholinergic Receptor Imaging in Dystonia (NCT02689466) | National Institute of Neurological Disorders and Stroke (NINDS) | 2016-12-16 |
| Propensity to Develop Plasticity in the Parieto-Motor Networks in Dystonia From the Perspective of Abnormal High-Order Motor Processing (NCT02504905) | National Institute of Neurological Disorders and Stroke (NINDS) | 2015-08-20 |
| A Retrospective Chart Review of BOTOX® and Xeomin® for the Management of Cervical Dystonia and Blepharospasm (NCT02245958) | Allergan | 2015-08-01 |
| Novel Stimulation Patterns for the Treatment of Dystonia (NCT02468843) | University of Florida | 2015-07-01 |
| Integration of the Cervical Proprioceptive Signals in Patients With Cervical Dystonia (NCT02834871) | Fondation Ophtalmologique Adolphe de Rothschild | 2015-03-01 |
| Effect of Osteopathic Manipulative Medicine on Motor Function and Quality of Life in Cervical Dystonia (NCT02420106) | New York Institute of Technology | 2014-02-01 |
| Analysis of Three-dimensional Movements of the Head in Cervical Dystonia (NCT02069548) | Fondation Ophtalmologique Adolphe de Rothschild | 2014-02-01 |
| Post-marketing Surveillance of Administration of Botulinum Toxin Type B(NerBloc)-Investigation of the Clinical Condition in Patients With Change From Botulinum Toxin Type A (NCT02175719) | Eisai Co., Ltd. | 2013-04-16 |
| Post-marketing Surveillance of Administration of Botulinum Toxin Type B(NerBloc)-Investigation of the Clinical Condition and Safety in Patients With Cervical Dystonia (NCT02175693) | Eisai Co., Ltd. | 2013-04-02 |
| Identification of Optimal Stimulation Site for Cervical Dystonia Symptoms: An Exploratory Study (NCT01859247) | University of New Mexico | 2013-03-01 |
| Long Term Safety And Effectiveness Of Dysport® In Adults With Cervical Dystonia (NCT01753336) | Ipsen | 2013-03-01 |
| Efficacy and Safety of MEDITOXIN® in Cervical Dystonia (NCT03905304) | Medy-Tox | 2013-01-09 |
| A Retrospective Chart Review of BOTOX® and Xeomin® for the Treatment of Cervical Dystonia and Blepharospasm (NCT01814774) | Allergan | 2013-01-01 |
| Efficacy and Safety of DYSPORT® Using 2mL Dilution in Adults With Cervical Dystonia. (NCT01753310) | Ipsen | 2013-01-01 |
| Phase IV-Cervical Dystonia-INTEREST IN CD2 (NCT01753349) | Ipsen | 2012-12-01 |
| The Impact of Botulinum Toxin Treatment in Quality of Life of Cervical Dystonia Patients (NCT01664013) | Roongroj Bhidayasiri | 2012-10-01 |
| Insights Into Deep Brain Stimulation (DBS) for Cervical Dystonia (NCT01671527) | University of Florida | 2012-08-01 |
| Study for Determine the Safety and Efficacy of Clostridium Botulinum Toxin Type A in Subjects With Cervical Dystonia (NCT01588574) | Medy-Tox | 2012-08-01 |
| Longitudinal Study for Treatment With Botulinum Toxin A Injections in naïve and Pre-treated Patients Suffering From Cervical Dystonia [CD-NIS-Longterm] (NCT01840462) | Ipsen | 2012-07-01 |
| Clinical and Kinematic Assessment for Determination of Botox® Injection Parameters in Cervical Dystonia (NCT02662530) | Western University, Canada | 2012-01-01 |
| Study Comparing Short Term Efficacy of Dysport and Dysport NG to Placebo, and to Assess Efficacy and Safety of Dysport NG of Subjects With Cervical Dystonia (NCT01261611) | Ipsen | 2011-04-01 |
| DYSPORT™ Clinical & Health Economics Outcomes Registry in Cervical Dystonia (NCT01314365) | Ipsen | 2011-04-01 |
| Static Graviceptive Functions in Patients With Cervical Dystonia (CD) (NCT01180270) | Kirsten Elwischger | 2010-06-01 |
| Effects of Botulinum Toxin in Cervical Dystonia (NCT01056861) | Henry Ford Health System | 2010-01-01 |
| A Study to Compare Dysport® and Botox® in the Treatment of Cervical Dystonia (NCT00950664) | Seoul National University Hospital | 2009-08-01 |
| CD-PROBE: Cervical Dystonia Patient Registry for the Observation of onabotulinumtoxinA Efficacy (NCT00836017) | Allergan | 2009-01-01 |
| Botox for Cervical Dystonia Following EMG Mapping (NCT00773253) | University of California, San Francisco | 2008-04-01 |
| Specialized Physiotherapy Program for Cervical Dystonia (NCT00703287) | Dr Donald Grosset | 2008-01-01 |
| Study to Evaluate Safety, Efficacy of Botulinum Toxin Type A in Patients With Cervical Dystonia (NCT00564681) | Allergan | 2007-12-01 |
| Daily Dystonia Practice - A Trial to Investigate NT 201, the Duration of Treatment Effect After One Injection Session and in Long-term Treatment in Cervical Dystonia (NCT00541905) | Merz Pharmaceuticals GmbH | 2007-09-01 |
| Efficacy of Dronabinol for the Treatment of Cervical Dystonia (NCT00418925) | University Health Network, Toronto | 2006-09-01 |
| IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Cervical Dystonia (NCT00407030) | Merz Pharmaceuticals GmbH | 2006-07-01 |
| Plasticity in Cervical Dystonia (NCT00323765) | National Institute of Neurological Disorders and Stroke (NINDS) | 2006-05-05 |
| Open-label Extension Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia (NCT00288509) | Ipsen | 2006-02-01 |
| Keppra for Cervical Dystonia (NCT00760318) | University of South Florida | 2005-11-01 |
| Randomized, Placebo-Controlled Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia (NCT00257660) | Ipsen | 2005-10-10 |
| Deep Brain Stimulation to Treat Cervical Dystonia (NCT00132340) | National Institute of Neurological Disorders and Stroke (NINDS) | 2005-08-01 |
| Double-blind, Multicenter Study to Assess the Efficacy of Bilateral Pallidal Stimulation in Patients With Medically Refractory Primary Cervical Dystonia (NCT00148889) | German Parkinson Study Group (GPS) | 2005-07-01 |
| Study to Assess the Efficacy and Safety of Dysport® in Cervical Dystonia (NCT00447772) | Ipsen | 2004-10-01 |
| Post Marketing Surveillance Study of Dysport (NCT00210431) | Ipsen | 2004-10-01 |
| Botulinum Toxin Type A (Botox) for the Treatment of Cervical Dystonia and Upper Thoracic Muscular Pain (NCT00178945) | Vanderbilt University | 2004-03-01 |
| A Multicenter Pilot Study of Pallidal Deep Brain Stimulation for Cervical Dystonia (NCT00132990) | University of Calgary | 2003-02-01 |
| Open Label Safety/Immunogenicity Study of MYOBLOC (Neurobloc; Botulinum Toxin Type B) in Patients With Cervical Dystonia (NCT00702754) | Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC | 2001-06-01 |